|
þ
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended October 31, 2017
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from to
|
South Dakota
(State or other jurisdiction of incorporation or organization)
|
|
46-0246171
(I.R.S. Employer Identification No.)
|
Large accelerated filer þ
|
|
Accelerated filer o
|
Non-accelerated filer o (Do not check if a smaller reporting company)
|
|
Smaller reporting company o
|
Emerging growth company o
|
|
|
|
|
PAGE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
|
Item 4. Mine Safety Disclosures
|
|
(dollars and shares in thousands, except per-share data)
|
October 31,
2017 |
|
January 31,
2017 |
|
October 31,
2016 |
||||||
ASSETS
|
|
|
|
|
|
||||||
Current assets
|
|
|
|
|
|
||||||
Cash and cash equivalents
|
$
|
36,873
|
|
|
$
|
50,648
|
|
|
$
|
46,313
|
|
Accounts receivable, net
|
59,573
|
|
|
43,143
|
|
|
39,554
|
|
|||
Inventories
|
53,481
|
|
|
42,336
|
|
|
42,813
|
|
|||
Other current assets
|
3,910
|
|
|
2,689
|
|
|
2,747
|
|
|||
Total current assets
|
153,837
|
|
|
138,816
|
|
|
131,427
|
|
|||
|
|
|
|
|
|
||||||
Property, plant and equipment, net
|
105,651
|
|
|
106,324
|
|
|
108,948
|
|
|||
Goodwill
|
46,752
|
|
|
40,649
|
|
|
40,703
|
|
|||
Amortizable intangible assets, net
|
11,375
|
|
|
12,048
|
|
|
12,511
|
|
|||
Other assets
|
2,926
|
|
|
3,672
|
|
|
3,746
|
|
|||
TOTAL ASSETS
|
$
|
320,541
|
|
|
$
|
301,509
|
|
|
$
|
297,335
|
|
|
|
|
|
|
|
||||||
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
|
|
|
|
||||||
Current liabilities
|
|
|
|
|
|
||||||
Accounts payable
|
$
|
13,383
|
|
|
$
|
8,467
|
|
|
$
|
9,377
|
|
Accrued liabilities
|
21,645
|
|
|
18,055
|
|
|
14,708
|
|
|||
Customer advances
|
908
|
|
|
1,860
|
|
|
1,154
|
|
|||
Total current liabilities
|
35,936
|
|
|
28,382
|
|
|
25,239
|
|
|||
|
|
|
|
|
|
||||||
Other liabilities
|
13,456
|
|
|
13,696
|
|
|
12,134
|
|
|||
|
|
|
|
|
|
||||||
Commitments and contingencies
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
|
|
|
|
|
||||||
Shareholders' equity
|
|
|
|
|
|
||||||
Common stock, $1 par value, authorized shares 100,000; issued 67,088; 67,060; and 67,060, respectively
|
67,088
|
|
|
67,060
|
|
|
67,060
|
|
|||
Paid-in capital
|
58,484
|
|
|
55,795
|
|
|
55,703
|
|
|||
Retained earnings
|
249,034
|
|
|
230,649
|
|
|
230,957
|
|
|||
Accumulated other comprehensive income (loss)
|
(3,058
|
)
|
|
(3,676
|
)
|
|
(3,361
|
)
|
|||
Treasury stock at cost, 31,332; 30,984; and 30,984 shares, respectively
|
(100,402
|
)
|
|
(90,402
|
)
|
|
(90,402
|
)
|
|||
Total Raven Industries, Inc. shareholders' equity
|
271,146
|
|
|
259,426
|
|
|
259,957
|
|
|||
Noncontrolling interest
|
3
|
|
|
5
|
|
|
5
|
|
|||
Total equity
|
271,149
|
|
|
259,431
|
|
|
259,962
|
|
|||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
$
|
320,541
|
|
|
$
|
301,509
|
|
|
$
|
297,335
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
(dollars in thousands, except per-share data)
|
October 31,
2017 |
|
October 31,
2016 |
|
October 31,
2017 |
|
October 31,
2016 |
||||||||
Net sales
|
$
|
101,349
|
|
|
$
|
72,522
|
|
|
$
|
281,494
|
|
|
$
|
208,480
|
|
Cost of sales
|
68,016
|
|
|
52,683
|
|
|
189,692
|
|
|
149,609
|
|
||||
Gross profit
|
33,333
|
|
|
19,839
|
|
|
91,802
|
|
|
58,871
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Research and development expenses
|
4,083
|
|
|
4,151
|
|
|
12,319
|
|
|
12,475
|
|
||||
Selling, general, and administrative expenses
|
11,421
|
|
|
8,212
|
|
|
31,476
|
|
|
24,174
|
|
||||
Long-lived asset impairment loss
|
—
|
|
|
87
|
|
|
259
|
|
|
87
|
|
||||
Operating income
|
17,829
|
|
|
7,389
|
|
|
47,748
|
|
|
22,135
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Other income (expense), net
|
(34
|
)
|
|
(273
|
)
|
|
(327
|
)
|
|
(579
|
)
|
||||
Income before income taxes
|
17,795
|
|
|
7,116
|
|
|
47,421
|
|
|
21,556
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Income tax expense
|
5,798
|
|
|
1,375
|
|
|
14,842
|
|
|
5,802
|
|
||||
Net income
|
11,997
|
|
|
5,741
|
|
|
32,579
|
|
|
15,754
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Net income (loss) attributable to the noncontrolling interest
|
(1
|
)
|
|
—
|
|
|
(2
|
)
|
|
1
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Net income attributable to Raven Industries, Inc.
|
$
|
11,998
|
|
|
$
|
5,741
|
|
|
$
|
32,581
|
|
|
$
|
15,753
|
|
|
|
|
|
|
|
|
|
||||||||
Net income per common share:
|
|
|
|
|
|
|
|
||||||||
─ Basic
|
$
|
0.33
|
|
|
$
|
0.16
|
|
|
$
|
0.90
|
|
|
$
|
0.43
|
|
─ Diluted
|
$
|
0.33
|
|
|
$
|
0.16
|
|
|
$
|
0.89
|
|
|
$
|
0.43
|
|
|
|
|
|
|
|
|
|
||||||||
Cash dividends paid per common share
|
$
|
0.13
|
|
|
$
|
0.13
|
|
|
$
|
0.39
|
|
|
$
|
0.39
|
|
|
|
|
|
|
|
|
|
||||||||
Comprehensive income (loss):
|
|
|
|
|
|
|
|
||||||||
Net income
|
$
|
11,997
|
|
|
$
|
5,741
|
|
|
$
|
32,579
|
|
|
$
|
15,754
|
|
|
|
|
|
|
|
|
|
||||||||
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation
|
(185
|
)
|
|
(201
|
)
|
|
637
|
|
|
146
|
|
||||
Postretirement benefits, net of income tax benefit (expense) of $4, $2, $11 and $4, respectively
|
(6
|
)
|
|
(2
|
)
|
|
(19
|
)
|
|
(6
|
)
|
||||
Other comprehensive income (loss), net of tax
|
(191
|
)
|
|
(203
|
)
|
|
618
|
|
|
140
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Comprehensive income
|
11,806
|
|
|
5,538
|
|
|
33,197
|
|
|
15,894
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Comprehensive income (loss) attributable to noncontrolling interest
|
(1
|
)
|
|
—
|
|
|
(2
|
)
|
|
1
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Comprehensive income attributable to Raven Industries, Inc.
|
$
|
11,807
|
|
|
$
|
5,538
|
|
|
$
|
33,199
|
|
|
$
|
15,893
|
|
|
$1 Par Common Stock
|
Paid-in Capital
|
Treasury Stock
|
Retained Earnings
|
Accumulated Other Comprehensive Income (Loss)
|
Raven Industries, Inc. Equity
|
Non- controlling Interest
|
Total Equity
|
||||||||||||||||||
(dollars in thousands, except per-share amounts)
|
Shares
|
Cost
|
||||||||||||||||||||||||
Balance January 31, 2016
|
$
|
67,006
|
|
$
|
53,907
|
|
30,500
|
|
$
|
(82,700
|
)
|
$
|
229,443
|
|
$
|
(3,501
|
)
|
$
|
264,155
|
|
$
|
74
|
|
$
|
264,229
|
|
Net income
|
—
|
|
—
|
|
—
|
|
—
|
|
15,753
|
|
—
|
|
15,753
|
|
1
|
|
15,754
|
|
||||||||
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Cumulative foreign currency translation adjustment
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
146
|
|
146
|
|
—
|
|
146
|
|
||||||||
Postretirement benefits reclassified from accumulated other comprehensive income (loss) after tax benefit of $4
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(6
|
)
|
(6
|
)
|
—
|
|
(6
|
)
|
||||||||
Cash dividends ($0.39 per share)
|
—
|
|
161
|
|
—
|
|
—
|
|
(14,239
|
)
|
—
|
|
(14,078
|
)
|
—
|
|
(14,078
|
)
|
||||||||
Dividends of less than wholly-owned subsidiary attributable to non-controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(70
|
)
|
(70
|
)
|
||||||||
Shares issued on vesting of stock units, net of shares withheld for employee taxes
|
35
|
|
(291
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
(256
|
)
|
—
|
|
(256
|
)
|
||||||||
Director shares issued
|
19
|
|
(19
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Shares repurchased
|
—
|
|
—
|
|
484
|
|
(7,702
|
)
|
—
|
|
—
|
|
(7,702
|
)
|
—
|
|
(7,702
|
)
|
||||||||
Share-based compensation
|
—
|
|
2,291
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2,291
|
|
—
|
|
2,291
|
|
||||||||
Income tax impact related to share-based compensation
|
—
|
|
(346
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
(346
|
)
|
—
|
|
(346
|
)
|
||||||||
Balance October 31, 2016
|
$
|
67,060
|
|
$
|
55,703
|
|
30,984
|
|
$
|
(90,402
|
)
|
$
|
230,957
|
|
$
|
(3,361
|
)
|
$
|
259,957
|
|
$
|
5
|
|
$
|
259,962
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance January 31, 2017
|
$
|
67,060
|
|
$
|
55,795
|
|
30,984
|
|
$
|
(90,402
|
)
|
$
|
230,649
|
|
$
|
(3,676
|
)
|
$
|
259,426
|
|
$
|
5
|
|
$
|
259,431
|
|
Net income
|
—
|
|
—
|
|
—
|
|
—
|
|
32,581
|
|
—
|
|
32,581
|
|
(2
|
)
|
32,579
|
|
||||||||
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Cumulative foreign currency translation adjustment
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
637
|
|
637
|
|
—
|
|
637
|
|
||||||||
Postretirement benefits reclassified from accumulated other comprehensive income (loss) after tax benefit of $11
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(19
|
)
|
(19
|
)
|
—
|
|
(19
|
)
|
||||||||
Cash dividends ($0.39 per share)
|
—
|
|
164
|
|
—
|
|
—
|
|
(14,196
|
)
|
—
|
|
(14,032
|
)
|
—
|
|
(14,032
|
)
|
||||||||
Shares issued on stock options exercised, net of shares withheld for employee taxes
|
13
|
|
(170
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
(157
|
)
|
—
|
|
(157
|
)
|
||||||||
Shares issued on vesting of stock units, net of shares withheld for employee taxes
|
11
|
|
(162
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
(151
|
)
|
—
|
|
(151
|
)
|
||||||||
Director shares issued
|
4
|
|
(4
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Shares repurchased
|
—
|
|
—
|
|
348
|
|
(10,000
|
)
|
—
|
|
—
|
|
(10,000
|
)
|
—
|
|
(10,000
|
)
|
||||||||
Share-based compensation
|
—
|
|
2,861
|
|
—
|
|
—
|
|
—
|
|
—
|
|
2,861
|
|
—
|
|
2,861
|
|
||||||||
Balance October 31, 2017
|
$
|
67,088
|
|
$
|
58,484
|
|
31,332
|
|
$
|
(100,402
|
)
|
$
|
249,034
|
|
$
|
(3,058
|
)
|
$
|
271,146
|
|
$
|
3
|
|
$
|
271,149
|
|
|
Nine Months Ended
|
||||||
(dollars in thousands)
|
October 31,
2017 |
|
October 31,
2016 |
||||
OPERATING ACTIVITIES:
|
|
|
|
||||
Net income
|
$
|
32,579
|
|
|
$
|
15,754
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
10,985
|
|
|
11,526
|
|
||
Change in fair value of acquisition-related contingent consideration
|
198
|
|
|
(41
|
)
|
||
Long-lived asset impairment loss
|
259
|
|
|
87
|
|
||
Loss from equity investment
|
247
|
|
|
223
|
|
||
Deferred income taxes
|
(1,035
|
)
|
|
(290
|
)
|
||
Share-based compensation expense
|
2,861
|
|
|
2,291
|
|
||
Other operating activities, net
|
868
|
|
|
8
|
|
||
Change in operating assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
(8,160
|
)
|
|
(1,620
|
)
|
||
Inventories
|
(9,213
|
)
|
|
3,048
|
|
||
Other assets
|
(897
|
)
|
|
(135
|
)
|
||
Operating liabilities
|
2,142
|
|
|
7,834
|
|
||
Net cash provided by operating activities
|
30,834
|
|
|
38,685
|
|
||
|
|
|
|
||||
INVESTING ACTIVITIES:
|
|
|
|
||||
Capital expenditures
|
(7,003
|
)
|
|
(3,901
|
)
|
||
Payments related to business acquisitions
|
(12,700
|
)
|
|
—
|
|
||
Proceeds from sale or maturity of investments
|
250
|
|
|
250
|
|
||
Purchases of investments
|
(255
|
)
|
|
(750
|
)
|
||
(Disbursements) proceeds from settlement of liabilities, sale of assets
|
(333
|
)
|
|
1,145
|
|
||
Other investing activities
|
(36
|
)
|
|
(498
|
)
|
||
Net cash used in investing activities
|
(20,077
|
)
|
|
(3,754
|
)
|
||
|
|
|
|
||||
FINANCING ACTIVITIES:
|
|
|
|
||||
Dividends paid
|
(14,032
|
)
|
|
(14,148
|
)
|
||
Payments for common shares repurchased
|
(10,000
|
)
|
|
(7,702
|
)
|
||
Payments of acquisition-related contingent liability
|
(364
|
)
|
|
(318
|
)
|
||
Restricted stock units vested and issued
|
(151
|
)
|
|
(256
|
)
|
||
Employee stock option exercises
|
(157
|
)
|
|
—
|
|
||
Net cash used in financing activities
|
(24,704
|
)
|
|
(22,424
|
)
|
||
|
|
|
|
||||
Effect of exchange rate changes on cash
|
172
|
|
|
24
|
|
||
|
|
|
|
||||
Net increase (decrease) in cash and cash equivalents
|
(13,775
|
)
|
|
12,531
|
|
||
Cash and cash equivalents at beginning of year
|
50,648
|
|
|
33,782
|
|
||
Cash and cash equivalents at end of period
|
$
|
36,873
|
|
|
$
|
46,313
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||
|
October 31,
2017 |
|
October 31,
2016 |
|
October 31,
2017 |
|
October 31,
2016 |
Anti-dilutive options and restricted stock units
|
338,244
|
|
653,513
|
|
385,157
|
|
922,041
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 31,
2017 |
|
October 31,
2016 |
|
October 31,
2017 |
|
October 31,
2016 |
||||||||
Numerator:
|
|
|
|
|
|
|
|
||||||||
Net income attributable to Raven Industries, Inc.
|
$
|
11,998
|
|
|
$
|
5,741
|
|
|
$
|
32,581
|
|
|
$
|
15,753
|
|
|
|
|
|
|
|
|
|
||||||||
Denominator:
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding
|
35,829,880
|
|
|
36,076,259
|
|
|
36,002,024
|
|
|
36,164,468
|
|
||||
Weighted average fully vested stock units outstanding
|
109,558
|
|
|
97,716
|
|
|
105,830
|
|
|
100,595
|
|
||||
Denominator for basic calculation
|
35,939,438
|
|
|
36,173,975
|
|
|
36,107,854
|
|
|
36,265,063
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding
|
35,829,880
|
|
|
36,076,259
|
|
|
36,002,024
|
|
|
36,164,468
|
|
||||
Weighted average fully vested stock units outstanding
|
109,558
|
|
|
97,716
|
|
|
105,830
|
|
|
100,595
|
|
||||
Dilutive impact of stock options and restricted stock units
|
380,997
|
|
|
122,270
|
|
|
369,339
|
|
|
70,102
|
|
||||
Denominator for diluted calculation
|
36,320,435
|
|
|
36,296,245
|
|
|
36,477,193
|
|
|
36,335,165
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Net income per share ─ basic
|
$
|
0.33
|
|
|
$
|
0.16
|
|
|
$
|
0.90
|
|
|
$
|
0.43
|
|
Net income per share ─ diluted
|
$
|
0.33
|
|
|
$
|
0.16
|
|
|
$
|
0.89
|
|
|
$
|
0.43
|
|
|
|
October 31, 2017
|
|
January 31, 2017
|
|
October 31, 2016
|
||||||
Accounts receivable, net:
|
|
|
|
|
|
|
||||||
Trade accounts
|
|
$
|
60,621
|
|
|
$
|
43,834
|
|
|
$
|
40,257
|
|
Allowance for doubtful accounts
|
|
(1,048
|
)
|
|
(691
|
)
|
|
(703
|
)
|
|||
|
|
$
|
59,573
|
|
|
$
|
43,143
|
|
|
$
|
39,554
|
|
Inventories:
|
|
|
|
|
|
|
||||||
Finished goods
|
|
$
|
7,063
|
|
|
$
|
5,438
|
|
|
$
|
5,686
|
|
In process
|
|
1,035
|
|
|
2,288
|
|
|
2,325
|
|
|||
Materials
|
|
45,383
|
|
|
34,610
|
|
|
34,802
|
|
|||
|
|
$
|
53,481
|
|
|
$
|
42,336
|
|
|
$
|
42,813
|
|
Other current assets:
|
|
|
|
|
|
|
||||||
Insurance policy benefit
|
|
$
|
593
|
|
|
$
|
802
|
|
|
$
|
776
|
|
Income tax receivable
|
|
269
|
|
|
604
|
|
|
228
|
|
|||
Receivable from sale of business
|
|
17
|
|
|
28
|
|
|
71
|
|
|||
Prepaid expenses and other
|
|
3,031
|
|
|
1,255
|
|
|
1,672
|
|
|||
|
|
$
|
3,910
|
|
|
$
|
2,689
|
|
|
$
|
2,747
|
|
Property, plant and equipment, net:
|
|
|
|
|
|
|
||||||
Land
|
|
$
|
3,234
|
|
|
$
|
3,054
|
|
|
$
|
3,054
|
|
Buildings and improvements
|
|
80,009
|
|
|
77,817
|
|
|
78,674
|
|
|||
Machinery and equipment
|
|
147,723
|
|
|
142,471
|
|
|
142,946
|
|
|||
Accumulated depreciation
|
|
(125,315
|
)
|
|
(117,018
|
)
|
|
(115,726
|
)
|
|||
|
|
$
|
105,651
|
|
|
$
|
106,324
|
|
|
$
|
108,948
|
|
Other assets:
|
|
|
|
|
|
|
||||||
Equity method investments
|
|
$
|
1,884
|
|
|
$
|
2,371
|
|
|
$
|
2,346
|
|
Deferred income taxes
|
|
18
|
|
|
18
|
|
|
65
|
|
|||
Other
|
|
1,024
|
|
|
1,283
|
|
|
1,335
|
|
|||
|
|
$
|
2,926
|
|
|
$
|
3,672
|
|
|
$
|
3,746
|
|
Accrued liabilities:
|
|
|
|
|
|
|
||||||
Salaries and related
|
|
$
|
6,464
|
|
|
$
|
6,286
|
|
|
$
|
3,931
|
|
Benefits
|
|
4,128
|
|
|
3,960
|
|
|
3,720
|
|
|||
Insurance obligations
|
|
3,106
|
|
|
2,400
|
|
|
2,022
|
|
|||
Warranties
|
|
1,217
|
|
|
1,547
|
|
|
1,852
|
|
|||
Income taxes
|
|
1,668
|
|
|
498
|
|
|
332
|
|
|||
Other taxes
|
|
1,446
|
|
|
1,540
|
|
|
1,230
|
|
|||
Acquisition-related contingent consideration
|
|
815
|
|
|
445
|
|
|
396
|
|
|||
Other
|
|
2,801
|
|
|
1,379
|
|
|
1,225
|
|
|||
|
|
$
|
21,645
|
|
|
$
|
18,055
|
|
|
$
|
14,708
|
|
Other liabilities:
|
|
|
|
|
|
|
||||||
Postretirement benefits
|
|
$
|
8,110
|
|
|
$
|
8,054
|
|
|
$
|
7,714
|
|
Acquisition-related contingent consideration
|
|
2,016
|
|
|
1,397
|
|
|
1,385
|
|
|||
Deferred income taxes
|
|
393
|
|
|
1,421
|
|
|
257
|
|
|||
Uncertain tax positions
|
|
2,584
|
|
|
2,610
|
|
|
2,778
|
|
|||
Other
|
|
353
|
|
|
214
|
|
|
—
|
|
|||
|
|
$
|
13,456
|
|
|
$
|
13,696
|
|
|
$
|
12,134
|
|
|
October 31, 2017
|
||
Assets held for sale
|
|
||
Inventories
|
$
|
3,000
|
|
Other current assets
|
79
|
|
|
Total current assets held for sale
|
3,079
|
|
|
Property, plant and equipment, net
|
227
|
|
|
Goodwill
|
102
|
|
|
Amortizable intangible assets, net
|
358
|
|
|
Other assets
|
17
|
|
|
Total assets held for sale
|
$
|
3,783
|
|
|
|
||
Liabilities held for sale
|
|
||
Current liabilities
|
$
|
392
|
|
Other long-term liabilities
|
127
|
|
|
Total liabilities held for sale
|
$
|
519
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 31,
2017 |
|
October 31,
2016 |
|
October 31,
2017 |
|
October 31,
2016 |
||||||||
Beginning balance
|
$
|
1,567
|
|
|
$
|
1,901
|
|
|
$
|
1,741
|
|
|
$
|
2,059
|
|
Fair value of contingent consideration acquired
|
1,256
|
|
|
—
|
|
|
1,256
|
|
|
—
|
|
||||
Change in fair value of the liability
|
52
|
|
|
(165
|
)
|
|
198
|
|
|
(41
|
)
|
||||
Contingent consideration earn-out paid
|
(44
|
)
|
|
(36
|
)
|
|
(364
|
)
|
|
(318
|
)
|
||||
Ending balance
|
$
|
2,831
|
|
|
$
|
1,700
|
|
|
$
|
2,831
|
|
|
$
|
1,700
|
|
|
|
|
|
|
|
|
|
||||||||
Classification of liability in the Consolidated balance sheet
|
|
|
|
|
|
|
|
||||||||
Accrued Liabilities
|
|
|
|
|
$
|
815
|
|
|
$
|
315
|
|
||||
Other Liabilities, long-term
|
|
|
|
|
2,016
|
|
|
1,385
|
|
||||||
Balance at October 31, 2017
|
|
|
|
|
$
|
2,831
|
|
|
$
|
1,700
|
|
||||
|
|
|
|
|
|
|
|
|
|
Applied
Technology
|
|
Engineered
Films
|
|
Aerostar
|
|
Total
|
||||||||
Balance at January 31, 2017
|
|
$
|
12,342
|
|
|
$
|
27,518
|
|
|
$
|
789
|
|
|
$
|
40,649
|
|
Additions due to business combinations
|
|
—
|
|
|
5,941
|
|
|
—
|
|
|
5,941
|
|
||||
Divestiture of business
|
|
—
|
|
|
—
|
|
|
(52
|
)
|
|
(52
|
)
|
||||
Foreign currency translation adjustment
|
|
214
|
|
|
—
|
|
|
—
|
|
|
214
|
|
||||
Balance at October 31, 2017
|
|
$
|
12,556
|
|
|
$
|
33,459
|
|
|
$
|
737
|
|
|
$
|
46,752
|
|
|
|
|
|
|
|
|
|
|
||||||||
Balance at January 31, 2016
|
|
$
|
12,365
|
|
|
$
|
27,518
|
|
|
$
|
789
|
|
|
$
|
40,672
|
|
Foreign currency translation adjustment
|
|
31
|
|
|
—
|
|
|
—
|
|
|
31
|
|
||||
Balance at October 31, 2016
|
|
$
|
12,396
|
|
|
$
|
27,518
|
|
|
$
|
789
|
|
|
$
|
40,703
|
|
|
October 31, 2017
|
|
January 31, 2017
|
|
October 31, 2016
|
||||||||||||||||||||||||
|
|
Accumulated
|
|
|
|
Accumulated
|
|
|
|
Accumulated
|
|
||||||||||||||||||
|
Amount
|
amortization
|
Net
|
|
Amount
|
amortization
|
Net
|
|
Amount
|
amortization
|
Net
|
||||||||||||||||||
Existing technology
|
$
|
7,218
|
|
$
|
(6,854
|
)
|
$
|
364
|
|
|
$
|
7,136
|
|
$
|
(6,553
|
)
|
$
|
583
|
|
|
$
|
7,157
|
|
$
|
(6,490
|
)
|
$
|
667
|
|
Customer relationships
|
13,220
|
|
(4,503
|
)
|
8,717
|
|
|
12,987
|
|
(3,680
|
)
|
9,307
|
|
|
13,000
|
|
(3,421
|
)
|
9,579
|
|
|||||||||
Patents and other intangibles
|
4,708
|
|
(2,414
|
)
|
2,294
|
|
|
4,378
|
|
(2,220
|
)
|
2,158
|
|
|
4,427
|
|
(2,162
|
)
|
2,265
|
|
|||||||||
Total
|
$
|
25,146
|
|
$
|
(13,771
|
)
|
$
|
11,375
|
|
|
$
|
24,501
|
|
$
|
(12,453
|
)
|
$
|
12,048
|
|
|
$
|
24,584
|
|
$
|
(12,073
|
)
|
$
|
12,511
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 31,
2017 |
|
October 31,
2016 |
|
October 31,
2017 |
|
October 31,
2016 |
||||||||
Service cost
|
$
|
21
|
|
|
$
|
20
|
|
|
$
|
64
|
|
|
$
|
60
|
|
Interest cost
|
83
|
|
|
83
|
|
|
247
|
|
|
249
|
|
||||
Amortization of actuarial losses
|
30
|
|
|
36
|
|
|
90
|
|
|
110
|
|
||||
Amortization of unrecognized gains in prior service cost
|
(40
|
)
|
|
(40
|
)
|
|
(120
|
)
|
|
(120
|
)
|
||||
Net periodic benefit cost
|
$
|
94
|
|
|
$
|
99
|
|
|
$
|
281
|
|
|
$
|
299
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 31,
2017 |
|
October 31,
2016 |
|
October 31,
2017 |
|
October 31,
2016 |
||||||||
Beginning balance
|
$
|
2,265
|
|
|
$
|
2,076
|
|
|
$
|
1,547
|
|
|
$
|
1,835
|
|
Change in provision
|
(274
|
)
|
|
202
|
|
|
1,504
|
|
|
1,288
|
|
||||
Settlements made
|
(774
|
)
|
|
(426
|
)
|
|
(1,834
|
)
|
|
(1,271
|
)
|
||||
Ending balance
|
$
|
1,217
|
|
|
$
|
1,852
|
|
|
$
|
1,217
|
|
|
$
|
1,852
|
|
|
Nine Months Ended
|
||||
|
October 31, 2017
|
|
October 31, 2016
|
||
Risk-free interest rate
|
1.68
|
%
|
|
1.05
|
%
|
Expected dividend yield
|
1.78
|
%
|
|
3.33
|
%
|
Expected volatility factor
|
33.87
|
%
|
|
32.61
|
%
|
Expected option term (in years)
|
4.25
|
|
|
4.00
|
|
|
|
|
|
||
Weighted average grant date fair value
|
$7.35
|
|
$3.05
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
October 31,
2017 |
|
October 31,
2016 |
|
October 31,
2017 |
|
October 31,
2016 |
||||||||
Net sales
|
|
|
|
|
|
|
|
||||||||
Applied Technology
|
$
|
25,319
|
|
|
$
|
25,203
|
|
|
$
|
94,233
|
|
|
$
|
79,327
|
|
Engineered Films
|
65,108
|
|
|
38,551
|
|
|
157,691
|
|
|
104,307
|
|
||||
Aerostar
|
11,103
|
|
|
9,003
|
|
|
30,078
|
|
|
25,313
|
|
||||
Intersegment eliminations (a)
|
(181
|
)
|
|
(235
|
)
|
|
(508
|
)
|
|
(467
|
)
|
||||
Consolidated net sales
|
$
|
101,349
|
|
|
$
|
72,522
|
|
|
$
|
281,494
|
|
|
$
|
208,480
|
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss)(b)
|
|
|
|
|
|
|
|
||||||||
Applied Technology
|
$
|
5,357
|
|
|
$
|
6,415
|
|
|
$
|
25,447
|
|
|
$
|
20,280
|
|
Engineered Films
|
17,115
|
|
|
7,129
|
|
|
35,386
|
|
|
17,666
|
|
||||
Aerostar(c)
|
1,359
|
|
|
(1,375
|
)
|
|
4,165
|
|
|
(1,804
|
)
|
||||
Intersegment eliminations
|
(12
|
)
|
|
(16
|
)
|
|
(3
|
)
|
|
(21
|
)
|
||||
Total reportable segment income
|
23,819
|
|
|
12,153
|
|
|
64,995
|
|
|
36,121
|
|
||||
General and administrative expenses(d)
|
(5,990
|
)
|
|
(4,764
|
)
|
|
(17,247
|
)
|
|
(13,986
|
)
|
||||
Consolidated operating income
|
$
|
17,829
|
|
|
$
|
7,389
|
|
|
$
|
47,748
|
|
|
$
|
22,135
|
|
•
|
Executive Summary
|
•
|
Results of Operations - Segment Analysis
|
•
|
Outlook
|
•
|
Liquidity and Capital Resources
|
•
|
Off-Balance Sheet Arrangements and Contractual Obligations
|
•
|
Critical Accounting Policies and Estimates
|
•
|
Accounting Pronouncements
|
•
|
Consolidated net sales, gross margin, operating income, operating margin, net income, and diluted earnings per share
|
•
|
Cash flow from operations and shareholder returns
|
•
|
Segment net sales, gross profit, gross margin, operating income, and operating margin. At the segment level, operating income does not include an allocation of general and administrative expenses.
|
•
|
Intentionally serve a set of diversified market segments with attractive near- and long-term growth prospects;
|
•
|
Consistently manage a pipeline of growth initiatives within our market segments;
|
•
|
Aggressively compete on quality, service, innovation, and peak performance;
|
•
|
Hold ourselves accountable for continuous improvement;
|
•
|
Value our balance sheet as a source of strength and stability with which to pursue strategic acquisitions; and
|
•
|
Make corporate responsibility a top priority.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||||||||
(dollars in thousands)
|
|
October 31,
2017 |
|
October 31,
2016 |
|
$ Change
|
|
% Change
|
|
October 31,
2017 |
|
October 31,
2016 |
|
$ Change
|
|
% Change
|
||||||||||||||
Net sales
|
|
$
|
25,319
|
|
|
$
|
25,203
|
|
|
$
|
116
|
|
|
0.5
|
%
|
|
$
|
94,233
|
|
|
$
|
79,327
|
|
|
$
|
14,906
|
|
|
18.8
|
%
|
Gross profit
|
|
10,790
|
|
|
10,636
|
|
|
154
|
|
|
1.4
|
%
|
|
41,554
|
|
|
32,911
|
|
|
8,643
|
|
|
26.3
|
%
|
||||||
Gross margin
|
|
42.6
|
%
|
|
42.2
|
%
|
|
|
|
|
|
44.1
|
%
|
|
41.5
|
%
|
|
|
|
|
||||||||||
Operating expenses
|
|
$
|
5,433
|
|
|
$
|
4,221
|
|
|
$
|
1,212
|
|
|
28.7
|
%
|
|
$
|
15,848
|
|
|
$
|
12,631
|
|
|
$
|
3,217
|
|
|
25.5
|
%
|
Operating expenses as % of sales
|
|
21.5
|
%
|
|
16.7
|
%
|
|
|
|
|
|
16.8
|
%
|
|
15.9
|
%
|
|
|
|
|
||||||||||
Long-lived asset impairment loss
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
$
|
259
|
|
|
$
|
—
|
|
|
|
|
|
|
|
||||
Operating income (loss)(1)
|
|
$
|
5,357
|
|
|
$
|
6,415
|
|
|
$
|
(1,058
|
)
|
|
(16.5
|
)%
|
|
$
|
25,447
|
|
|
$
|
20,280
|
|
|
$
|
5,167
|
|
|
25.5
|
%
|
Operating margin
|
|
21.2
|
%
|
|
25.5
|
%
|
|
|
|
|
|
27.0
|
%
|
|
25.6
|
%
|
|
|
|
|
||||||||||
(1) At the segment level, operating income does not include an allocation of general and administrative expenses.
|
•
|
Market conditions. Aftermarket sales channel demand remains subdued, and growth in the OEM sales channel has become more challenging in the third quarter of fiscal 2018. Although agriculture end market conditions deteriorated in the third quarter of fiscal 2018, the Company believes that overall the division is holding market share across product lines. Despite these challenging conditions, Applied Technology's marketplace strategy has capitalized on new product introductions through the first nine months of fiscal 2018. Successful new product introductions and expanded relationships with OEM partners are driving improved sales and market share gains versus the prior year.
|
•
|
Sales volume. Third quarter fiscal 2018 net sales were up slightly compared to $25.2 million in the third quarter of the prior year. Sales in the original equipment manufacturer (OEM) channel were up 10.3% while sales in the aftermarket channel were down 10.1% for the fiscal 2018 third quarter. Year-to-date sales increased 18.8% to $94.2 million compared to $79.3 million in the prior year. For the nine months ended October 31, 2017, sales in the OEM channel were up 39.2% while sales in the aftermarket channel were up 3.1% versus the prior year comparative period. The increases in net sales in the three- and nine-month periods were primarily driven by volume as pricing had minimal impact.
|
•
|
International sales. For the three-month period, international sales totaled $5.2 million, down 8.8% from $5.7 million in the prior year comparative period. Lower sales volume in Canada, and Europe were the primary drivers of this decrease. International sales represented 20.7% of segment revenue compared to 22.8% of segment revenue in the prior year comparative period. Year-to-date, international sales totaled $23.2 million, an increase of $0.1 million from a year ago. Year-to-date international sales represented 24.6% of segment sales compared to 29.1% in the prior year comparative period. Higher sales in Latin America, Europe, and Australia were mostly offset by a decrease in Canada. The sales increases in Europe reflect commercial synergies realized by the acquisition of SBG in fiscal 2015 as Applied Technology products are increasingly sold into this market.
|
•
|
Gross margin. Gross margin increased to 42.6% for the three months ended October 31, 2017 from 42.2% in the prior year comparative period. For the nine-month period ended October 31, 2017 gross margin increased to 44.1% from 41.5% in the fiscal 2017 comparative period. The nine-month period benefited more from higher sales volume and improved operating leverage.
|
•
|
Operating expenses. Fiscal 2018 third quarter operating expense as a percentage of net sales was 21.5%, up from 16.7% in the prior year third quarter. This increase is primarily driven by higher investment in the sales function and research and development activities, and higher legal expenses. These strategic investments will support the Company's long-term growth through new product introductions and an enhanced sales function. Year-to-date operating expense as a percentage of net sales was 16.8%, up from 15.9% in the prior year comparative period. The increase in the nine-month period is driven by investment in research and development and selling and marketing expenses related to new product introductions and to enhance our customer experience.
|
•
|
Long-lived asset impairment loss. As described in Note 7 Goodwill, Long-lived Assets, and Other Intangibles of the Notes to the Consolidated Financial Statements included in Item 1 of this Form 10-Q, during the first quarter of fiscal 2018 the Company determined that the intangible asset related to the investment in AgEagle was fully impaired due to the decrease in expected future cash flows. No impairments were recognized in the three-month period ended October 31, 2017 or the three- or nine-month periods ended October 31, 2016.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||||||||
(dollars in thousands)
|
|
October 31,
2017 |
|
October 31,
2016 |
|
$ Change
|
|
% Change
|
|
October 31,
2017 |
|
October 31,
2016 |
|
$ Change
|
|
% Change
|
||||||||||||||
Net sales
|
|
$
|
65,108
|
|
|
$
|
38,551
|
|
|
$
|
26,557
|
|
|
68.9
|
%
|
|
$
|
157,691
|
|
|
$
|
104,307
|
|
|
$
|
53,384
|
|
|
51.2
|
%
|
Gross profit
|
|
19,358
|
|
|
8,711
|
|
|
10,647
|
|
|
122.2
|
%
|
|
41,631
|
|
|
22,334
|
|
|
19,297
|
|
|
86.4
|
%
|
||||||
Gross margin
|
|
29.7
|
%
|
|
22.6
|
%
|
|
|
|
|
|
26.4
|
%
|
|
21.4
|
%
|
|
|
|
|
||||||||||
Operating expenses
|
|
$
|
2,243
|
|
|
$
|
1,582
|
|
|
$
|
661
|
|
|
41.8
|
%
|
|
$
|
6,245
|
|
|
$
|
4,668
|
|
|
$
|
1,577
|
|
|
33.8
|
%
|
Operating expenses as % of sales
|
|
3.4
|
%
|
|
4.1
|
%
|
|
|
|
|
|
4.0
|
%
|
|
4.5
|
%
|
|
|
|
|
||||||||||
Operating income (loss)(1)
|
|
$
|
17,115
|
|
|
$
|
7,129
|
|
|
$
|
9,986
|
|
|
140.1
|
%
|
|
$
|
35,386
|
|
|
$
|
17,666
|
|
|
$
|
17,720
|
|
|
100.3
|
%
|
Operating margin
|
|
26.3
|
%
|
|
18.5
|
%
|
|
|
|
|
|
22.4
|
%
|
|
16.9
|
%
|
|
|
|
|
||||||||||
(1) At the segment level, operating income does not include an allocation of general and administrative expenses.
|
•
|
Market conditions. End-market conditions in the geomembrane market, which constituted approximately 29 percent of the division's sales in the third quarter of fiscal 2018, have continued to improve from the market-bottom conditions reached last year. At the end of the third quarter of fiscal 2018, U.S. land-based rig counts have increased approximately 66% versus the third quarter of fiscal 2017. For the three- and nine-month periods ended October 31, 2017, sales into the geomembrane market were up approximately 125% and 135% year-over-year, respectively. As described in Note 6 Acquisitions of and Investments in Businesses and Technologies of the Notes to the Consolidated Financial Statements included in Item 1 of this Form 10-Q, during the third quarter of fiscal 2018 the Company closed on the acquisition of Colorado Lining International Inc. (CLI), further strengthening Engineered Films' presence in the geomembrane market. CLI contributed $5.2 million in sales during the three- and nine-month periods ended October 31, 2017 which was split between the geomembrane market and installation sales. For the three- and nine-month periods ended October 31, 2017, sales into the construction market were up approximately 61.8% and 27.5% year-over-year, respectively, which included $8.4 million in sales of hurricane recovery film. It has been several years since the Company last received a substantial increase in demand for hurricane recovery film. Sales of such film are generally less than $2.0 million on an annual basis. In April 2017, Engineered Films expanded its fabrication capabilities of geomembrane liner materials in south Texas by purchasing a new facility in Pleasanton, Texas and increased fabrication at the Company's location in Midland, Texas by adding production team members to service the increased demand in the geomembrane market. The Company does not model comparative market share position for its divisions, but based on the growth in the first nine months of fiscal 2018, the Company believes Engineered Films achieved sales growth due to improved end-market demand conditions and increased market share.
|
•
|
Sales volume and selling prices. Third quarter net sales were $65.1 million, an increase of $26.5 million, or 68.9%, compared to fiscal 2017 third quarter net sales of $38.6 million. Volume, measured in pounds sold, increased 52.6% and average selling price increased 4.5%. For the nine-month period ended October 31, 2017, Engineered Films' net sales were $157.7 million, an increase of $53.4 million, or 51.2%, compared to the nine-month period ended October 31, 2016. Volume, measured in pounds sold, increased 44.5% and average selling price increased 2.2%. All markets contributed to the higher sales in the three- and nine-month periods ended October 31, 2017.
|
•
|
Gross margin. For the three- and nine-month periods ended October 31, 2017, gross margin was 29.7% and 26.4%, respectively. The gross margin for the three- and nine-month periods ended October 31, 2016 was 22.6% and 21.4%, respectively. The improvement in gross margin was primarily due to higher sales volume and the resulting improvement in capacity utilization, but also benefited from continued spending discipline.
|
•
|
Operating expenses. Third quarter operating expenses were up $0.6 million or 41.8% compared to the prior year third quarter. As a percentage of net sales, operating expense was 3.4% in the current year three-month period as compared to 4.1% in the prior year comparative period. Year-to-date operating expenses were 4.0% as a percentage of net sales as compared to 4.5% in the prior year comparative period. The increase in sales volume in the three- and nine-month periods more than offset the additional costs to support sales growth and drove operating expenses as percentage of sales down 0.7 and 0.5 percentage points year-over-year, respectively.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||||||||||||||||
(dollars in thousands)
|
|
October 31,
2017 |
|
October 31,
2016 |
|
$ Change
|
|
% Change
|
|
October 31,
2017 |
|
October 31,
2016 |
|
$ Change
|
|
% Change
|
||||||||||||||
Net sales
|
|
$
|
11,103
|
|
|
$
|
9,003
|
|
|
$
|
2,100
|
|
|
23.3
|
%
|
|
$
|
30,078
|
|
|
$
|
25,313
|
|
|
$
|
4,765
|
|
|
18.8
|
%
|
Gross profit
|
|
3,197
|
|
|
508
|
|
|
2,689
|
|
|
529.3
|
%
|
|
8,620
|
|
|
3,647
|
|
|
4,973
|
|
|
136.4
|
%
|
||||||
Gross margin
|
|
28.8
|
%
|
|
5.6
|
%
|
|
|
|
|
|
28.7
|
%
|
|
14.4
|
%
|
|
|
|
|
||||||||||
Operating expenses
|
|
$
|
1,838
|
|
|
$
|
1,796
|
|
|
$
|
42
|
|
|
2.3
|
%
|
|
$
|
4,455
|
|
|
$
|
5,364
|
|
|
$
|
(909
|
)
|
|
(16.9
|
)%
|
Operating expenses as % of sales
|
|
16.6
|
%
|
|
19.9
|
%
|
|
|
|
|
|
14.8
|
%
|
|
21.2
|
%
|
|
|
|
|
||||||||||
Long-lived asset impairment loss
|
|
—
|
|
|
87
|
|
|
(87
|
)
|
|
|
|
—
|
|
|
87
|
|
|
$
|
(87
|
)
|
|
|
|||||||
Operating income (loss)(1)
|
|
$
|
1,359
|
|
|
$
|
(1,375
|
)
|
|
$
|
2,734
|
|
|
(198.8
|
)%
|
|
$
|
4,165
|
|
|
$
|
(1,804
|
)
|
|
$
|
5,969
|
|
|
(330.9
|
)%
|
Operating margin
|
|
12.2
|
%
|
|
(15.3
|
)%
|
|
|
|
|
|
13.8
|
%
|
|
(7.1
|
)%
|
|
|
|
|
||||||||||
(1) At the segment level, operating income does not include an allocation of general and administrative expenses.
|
•
|
Market conditions. Some of Aerostar's markets are subject to significant variability due to government spending and the timing of awards. Such conditions result in delays and uncertainties in certain opportunities important to the division's growth strategy. Despite these uncertainties, Aerostar is pioneering new markets with leading-edge applications of its stratospheric balloon platform. While it is particularly challenging to measure market share information for the Aerostar division and the Company does not model comparative market share position for any of its divisions, the Company believes that Aerostar's sales growth in the three- and nine-month periods was primarily the result of market share gains rather than overall growth of the market.
|
•
|
Sales volume. Net sales increased 23.3% from $9.0 million for the three-month period ended October 31, 2016 to $11.1 million for the three-month period ended October 31, 2017. Year-to-date sales were $30.1 million, up $4.8 million year-over-year, or 18.8%. The increase in both periods was driven principally by growth in the stratospheric balloon platform.
|
•
|
Gross margin. For the three-month period, gross margin increased from 5.6% to 28.8%. Gross margin increased from 14.4% to 28.7% in the nine-month period. The three- and nine-month periods ended October 31, 2017 include an inventory write-down adjustment of $0.4 million related to certain aerostat inventory. The three- and nine-month periods ended October 31, 2016 include an inventory write-down adjustment of $2.3 million related to certain radar inventory. The inventory write downs in the current and prior year were driven by strategic decisions to narrow certain offerings and thereby further enhance Aerostar’s focus on its stratospheric balloon platform. The remaining increase in gross margin for both periods was primarily driven by higher sales volume and the implementation of cost reductions as compared to the previous year.
|
•
|
Operating expenses. Third quarter fiscal 2018 operating expense was $1.8 million, or 16.6% of net sales, a decrease from 19.9% of net sales in the third quarter of fiscal 2017. Year-to-date operating expense as a percentage of net sales was 14.8%, down from 21.2% in the prior year. The three- and nine-month periods ended October 31, 2017 include a $0.5 million loss on the disposal of certain demonstration related equipment driven by strategic decisions to narrow certain offerings and thereby further enhance Aerostar’s focus on its stratospheric balloon platform. The decrease as a percentage of sales in both periods is primarily driven by higher sales and adjustments in operating expenses while focusing on strategic research and development spending.
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
(dollars in thousands)
|
|
October 31,
2017 |
|
October 31,
2016 |
|
October 31,
2017 |
|
October 31,
2016 |
||||||||
Administrative expenses
|
|
$
|
5,990
|
|
|
$
|
4,764
|
|
|
$
|
17,247
|
|
|
$
|
13,986
|
|
Administrative expenses as a % of sales
|
|
5.9
|
%
|
|
6.6
|
%
|
|
6.1
|
%
|
|
6.7
|
%
|
||||
Other income (expense), net
|
|
$
|
(34
|
)
|
|
$
|
(273
|
)
|
|
$
|
(327
|
)
|
|
$
|
(579
|
)
|
Effective tax rate
|
|
32.6
|
%
|
|
19.3
|
%
|
|
31.3
|
%
|
|
26.9
|
%
|
(dollars in thousands)
|
|
October 31,
2017 |
|
January 31,
2017 |
|
October 31,
2016 |
||||||
Cash and cash equivalents
|
|
$
|
36,873
|
|
|
$
|
50,648
|
|
|
$
|
46,313
|
|
|
|
Nine Months Ended
|
||||||
(dollars in thousands)
|
|
October 31, 2017
|
|
October 31, 2016
|
||||
Cash provided by operating activities
|
|
$
|
30,834
|
|
|
$
|
38,685
|
|
Cash used in investing activities
|
|
(20,077
|
)
|
|
(3,754
|
)
|
||
Cash used in financing activities
|
|
(24,704
|
)
|
|
(22,424
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
|
172
|
|
|
24
|
|
||
Net increase in cash and cash equivalents
|
|
$
|
(13,775
|
)
|
|
$
|
12,531
|
|
(dollars in thousands)
|
|
October 31, 2017
|
|
October 31, 2016
|
||||
Accounts receivable, net
|
|
$
|
59,573
|
|
|
$
|
39,554
|
|
Plus: Inventories
|
|
53,481
|
|
|
42,813
|
|
||
Less: Accounts payable
|
|
13,383
|
|
|
9,377
|
|
||
Net working capital(a)
|
|
$
|
99,671
|
|
|
$
|
72,990
|
|
|
|
|
|
|
||||
Annualized net sales(b)
|
|
$
|
405,396
|
|
|
$
|
290,088
|
|
Net working capital percentage(c)
|
|
24.6
|
%
|
|
25.2
|
%
|
||
(a) Net working capital is defined as accounts receivable (net) plus inventories less accounts payable.
|
||||||||
(b) Annualized net sales is defined as the most recent quarter net sales times four for each of the fiscal periods, respectively.
|
||||||||
(c) Net working capital percentage is defined as Net working capital divided by Annualized net sales for each of the fiscal periods, respectively.
|
ITEM 3.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
ITEM 4.
|
CONTROLS AND PROCEDURES
|
•
|
The Company’s controls relating to the response to the risks of material misstatement were not effectively designed.
|
◦
|
During the second quarter of fiscal 2018, we have redesigned and enhanced our controls and procedures around timely and appropriate identification, assessment, and response to risks of material misstatement. This included formalizing and redefining the risk categorization and risk rating methodology to appropriately assess and monitor identified risks on a quarterly basis.
|
•
|
The Company’s controls over the accounting for goodwill and long-lived assets, including finite-lived intangible assets, were not effectively designed and maintained, specifically, the controls related to the identification of the proper unit of account as well as the development and review of assumptions used in interim and annual impairment tests. This control deficiency resulted in the restatement of the Company’s financial statements for the three- and nine-month periods ended October 31, 2015, the fiscal year ended January 31, 2016, and the three-month period ended April 30, 2016.
|
◦
|
During the first quarter of fiscal 2018, management completed the following remediation efforts around the design deficiency:
|
▪
|
We have redesigned our specific procedures and controls associated with the identification of the proper unit of account.
|
▪
|
We have developed an enhanced risk assessment evaluation for the reporting unit for which a goodwill impairment analysis is being conducted.
|
▪
|
We have redesigned our controls associated with the development of a more precise revenue forecast for use in interim and annual impairment tests. For Aerostar, this specifically includes more precise contract-based revenue assumptions.
|
▪
|
We have redesigned our controls associated with all significant assumptions, model and data used in management's estimates relevant to assessing the valuation of goodwill and long-lived assets, including finite-lived intangible assets.
|
▪
|
Internal Audit has completed a design walkthrough of redesigned controls.
|
•
|
The Company’s controls over the completeness and accuracy of spreadsheets and system-generated reports used in internal control over financial reporting were not effectively designed and maintained
|
◦
|
During the second quarter of fiscal 2018, we have redesigned our controls for the identification and assessment of the completeness and accuracy of spreadsheets and system-generated reports used in internal control over financial reporting.
|
◦
|
During the second quarter of fiscal 2018, we have developed governance policy and procedures that will be used consistently by the organization to appropriately identify, assess, and manage risks related to the data integrity of spreadsheets and system-generated reports in internal control over financial reporting.
|
◦
|
During the third quarter of fiscal 2018, we have completed the baseline testing for those system-generated reports utilized in internal control over financial reporting that are subject to change management.
|
◦
|
During the third quarter of fiscal 2018, we have redesigned our controls to perform an analysis to identify changes made to system-generated reports utilized in the internal controls.
|
•
|
The Company’s controls related to the accounting for income taxes were not effectively designed and maintained, specifically the controls to assess that the income tax provision and related tax assets and liabilities are complete and accurate. This control deficiency resulted in adjustments to the income tax provision and related tax asset and liability
|
◦
|
Management completed the following remediation efforts around the deficiency:
|
•
|
We have redesigned specific processes and controls to augment the review of significant or unusual transactions performed by finance leadership to ensure that the relevant tax accounting implications are identified and considered.
|
•
|
Our Director of Taxation has improved our tax models and implemented multiple reconciliations to ensure the Company’s tax provision is properly reconciled and rolled-forward.
|
•
|
The Company’s controls over the existence of inventories were not effectively designed and maintained. Specifically, the controls to monitor that inventory subject to the cycle count program was counted at the frequency levels and accuracy rates required under the Company’s policy, and the controls to verify the existence of inventory held at third-party locations were not effectively designed and maintained.
|
◦
|
Management completed the following remediation efforts around the deficiency:
|
•
|
We have completed the transfer of the vast majority of inventory held at third-party locations to Company-owned facilities.
|
•
|
We have redesigned our controls over the completeness and accuracy of underlying information to monitor count dates for each item by location.
|
•
|
We have redesigned our controls over the completeness and accuracy of underlying information to calculate and monitor the historical cycle count accuracy results. We have also formalized procedures to establish specific accountability for investigation and analysis of identified variances.
|
•
|
We have redesigned our controls over baseline testing for all system-generated reports utilized in the internal controls over existence of inventories subject to the cycle count program.
|
•
|
We have completed an analysis to validate that inventory subject to the cycle count program is being counted at the frequency levels and accuracy rates required under the Company’s policy.
|
Period
|
|
Total number of shares purchased under the plan
|
|
Weighted average price paid per share (or unit)
|
|
Total amount purchased including commissions
|
|
Dollar value of shares (or units) that may be purchased under the plan
|
|||||||
August 1 to August 31, 2017
|
|
124,700
|
|
|
$
|
27.66
|
|
|
$
|
3,448,795
|
|
|
|
||
September 1 to September 30, 2017
|
|
223,586
|
|
|
29.30
|
|
|
6,551,197
|
|
|
|
||||
October 1 to October 31, 2017
|
|
—
|
|
|
|
|
—
|
|
|
|
|||||
Total as of and for the fiscal quarter ended October 31, 2017
|
|
348,286
|
|
|
$
|
28.71
|
|
|
$
|
9,999,992
|
|
|
$
|
2,959,349
|
|
Exhibit
Number
|
|
Description
|
|
|
|
|
Asset Purchase Agreement by and among Colorado Lining International, Inc., John B. Heap, Patrick Elliott, and Raven Industries, Inc. dated August 22, 2017.
|
|
|
|
|
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
101.INS
|
|
Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
|
|
RAVEN INDUSTRIES, INC.
|
|
||
|
|
|
||
|
/s/ Steven E. Brazones
|
|
||
|
Steven E. Brazones
|
|
||
|
Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
CONFIDENTIAL TREATMENT REQUESTED
|
Exhibit 2.1
|
|
[*] Indicates confidential portions omitted pursuant to a request for confidential treatment filed separately with the Securities and Exchange Commission.
|
|
Page
|
ARTICLE I. DEFINITIONS
|
1
|
1.1 Certain Definitions
|
1
|
1.2 Interpretation
|
12
|
|
|
ARTICLE II. PURCHASE AND SALE OF THE ACQUIRED ASSETS
|
12
|
2.1 Purchase and Sale of the Acquired Assets
|
12
|
2.2 Excluded Assets
|
13
|
2.3 Assumption of Certain Liabilities
|
14
|
2.4 Retained Liabilities
|
14
|
2.5 Nontransferable Assets
|
14
|
2.6 Inventory Count
|
15
|
2.7 Estimated Closing Purchase Price
|
15
|
2.8 Payment of Estimated Closing Purchase Price
|
15
|
2.9 Determination of the Final Closing Purchase Price
|
16
|
2.10 Closing
|
17
|
2.11 Closing Deliveries
|
17
|
2.12 Earnout Payments
|
19
|
2.13 Withholding
|
21
|
|
|
ARTICLE III. REPRESENTATIONS AND WARRANTIES OF SELLER AND SELLER STOCKHOLDERS
|
21
|
3.1 Organization
|
21
|
3.2 Equity Ownership
|
22
|
3.3 Authority, Validity and Enforceability
|
22
|
3.4 No Subsidiaries
|
22
|
3.5 No Conflict
|
22
|
3.6 Consents
|
22
|
3.7 Financial Statements; Undisclosed Liabilities
|
22
|
3.8 Inventory
|
23
|
3.9 Accounts Receivable
|
23
|
3.10 Absence of Certain Developments
|
23
|
3.11 Compliance with Laws; Governmental Authorizations; Licenses
|
23
|
3.12 Litigation
|
24
|
3.13 Real Property
|
24
|
3.14 Taxes
|
25
|
3.15 Environmental Matters
|
26
|
3.16 Employee Matters
|
27
|
3.17 Employee Benefit Plans
|
28
|
3.18 Intellectual Property Rights
|
29
|
3.19 Material Contracts
|
31
|
3.20 Insurance
|
33
|
3.21 Title to Assets
|
33
|
3.22 Affiliate Transactions
|
33
|
3.23 Brokers
|
33
|
3.24 Customers and Suppliers
|
33
|
3.25 Product Liability Claims
|
34
|
3.26 Warranties
|
34
|
3.27 Disclosure
|
34
|
|
Page
|
ARTICLE IV. REPRESENTATIONS AND WARRANTIES OF BUYER
|
34
|
4.1 Organization
|
34
|
4.2 Authority, Validity and Enforceability
|
34
|
4.3 No Conflicts
|
35
|
4.4 Consents
|
35
|
4.5 Brokers
|
35
|
|
|
ARTICLE V. COVENANTS AND AGREEMENTS
|
35
|
5.1 Access and Information
|
35
|
5.2 Conduct of Business Prior to Closing
|
36
|
5.3 Commercially Reasonable Efforts; Notification of Certain Events
|
37
|
5.4 Public Announcements
|
37
|
5.5 Employee Matters
|
37
|
5.6 Exclusivity
|
38
|
5.7 Tax Matters
|
39
|
5.8 Transfer of Certain Funds Received Post-Closing
|
40
|
5.9 Further Assurances
|
40
|
5.10 Insurance
|
41
|
5.11 Access to Records Post-Closing
|
41
|
5.12 Warranty Claims
|
42
|
|
|
ARTICLE VI. CONDITIONS TO CLOSING
|
42
|
6.1 Mutual Conditions
|
42
|
6.2 Conditions to the Obligations of Buyer
|
42
|
6.3 Conditions to the Obligations of Seller and Seller Stockholders
|
43
|
|
|
ARTICLE VII. TERMINATION
|
43
|
7.1 Termination
|
43
|
7.2 Effect of Termination
|
44
|
|
|
ARTICLE VIII. SURVIVAL; INDEMNIFICATION
|
|
8.1 Survival of Representations, Warranties and Covenants
|
44
|
8.2 Indemnification
|
45
|
8.3 Limitations on Liability; Calculation of Losses
|
46
|
8.4 Claims Procedures
|
46
|
8.5 Payment of Claim
|
47
|
8.6 Exclusive Remedy
|
48
|
8.7 Investigation
|
48
|
8.8 Treatment of Indemnity Payments
|
48
|
|
|
ARTICLE IX. MISCELLANEOUS
|
48
|
9.1 Notices
|
48
|
9.2 Exhibits and Schedules
|
49
|
9.3 Computation of Time
|
50
|
9.4 Expenses 50
|
50
|
9.5 Governing Law; Jurisdiction
|
50
|
9.6 Assignment; Successors and Assigns; No Third Party Rights
|
50
|
9.7 Counterparts
|
50
|
9.8 Titles and Headings
|
50
|
9.9 Entire Agreement
|
50
|
9.10 Severability
|
51
|
9.11 No Strict Construction
|
51
|
9.12 Specific Performance
|
51
|
9.13 Waiver of Jury Trial
|
51
|
9.14 Failure or Indulgence not Waiver
|
51
|
9.15 Amendments 51
|
51
|
Exhibits
|
|
Exhibit A
|
Form of Assignment and Assumption Agreement
|
Exhibit B
|
Form of Bill of Sale
|
Exhibit C
|
Form of Escrow Agreement
|
Exhibit D-1
|
Form of Patent Assignment
|
Exhibit D-2
|
Form of Trademark Assignment
|
Exhibit D-3
|
Form of Domain Name Assignment
|
Exhibit E-1
|
Form of Lease Agreement (Colorado Facility)
|
Exhibit E-2
|
Form of Lease Agreement (Texas Facility)
|
Exhibit F-1
|
Form of Noncompetition Agreement (Seller)
|
Exhibit F-2
|
Form of Noncompetition Agreement (Elliott)
|
Exhibit F-3
|
Form of Noncompetition Agreement (Heap)
|
|
|
Disclosure Schedules
|
|
Schedule 2.1(b)
|
Equipment
|
Schedule 2.1(e)
|
Assumed Contracts
|
Schedule 2.1(f)
|
Business Intellectual Property Rights
|
Schedule 2.1(h)
|
Prepaid Items, Backlogs, Advances, Deposits
|
Schedule 2.1(l)
|
Leased Real Property
|
Schedule 2.1(m)
|
Other Assets
|
Schedule 2.2(f)
|
Excluded Assets
|
Schedule 2.11(a)(iii)
|
Consents, Waivers and Approvals
|
Schedule 2.12(a)(ii)
|
Buyer Products
|
Schedule 3.2
|
Equity Ownership
|
Schedule 3.4
|
Subsidiaries
|
Schedule 3.6
|
Consents
|
Schedule 3.7
|
Financial Statements; Undisclosed Liabilities
|
Schedule 3.10
|
Absence of Certain Developments
|
Schedule 3.11(a)
|
Compliance with Laws; Governmental Authorizations; Licenses
|
Schedule 3.12
|
Litigation
|
Schedule 3.14 (a)
|
Tax Returns
|
Schedule 3.14 (e)
|
Tax Filings
|
Schedule 3.14 (f)
|
Tax Legal Requirements
|
Schedule 3.14 (i)
|
S-Corporation Filings
|
Schedule 3.16 (a)
|
Employee Matters
|
Schedule 3.16 (c)
|
Employees
|
Schedule 3.16 (d)
|
Former Employees
|
Schedule 3.17 (b)
|
Employee Benefit Plans
|
Schedule 3.18(a)
|
Owned Intellectual Property
|
Schedule 3.18(d)
|
Infringement
|
Schedule 3.19
|
Material Contracts
|
Schedule 3.20
|
Insurance
|
Schedule 3.22
|
Affiliate Transactions
|
Schedule 3.24(a)
|
Suppliers
|
Schedule 3.24(b)
|
Customers
|
Schedule 3.25
|
Product Liability Claims
|
Schedule 3.26
|
Warranties
|
Schedule 5.2
|
Conduct of Business Prior to Closing
|
Schedule 5.5(f)
|
M&A Qualified Beneficiaries
|
Schedule 5.10(a)
|
Discontinued Products Policy
|
Schedule 8.2(a)(iv)
|
Specific Indemnities
|
(c)
|
all accounts receivable of Seller (the “Accounts Receivable”);
|
(d)
|
all supplier and customer lists and pricing information relating to the Business;
|
(g)
|
all Permits related to the Business;
|
(m)
|
all assets listed on Schedule 2.1(m); and
|
(n)
|
all goodwill associated with the Business and the Acquired Assets.
|
(d)
|
all rights of Seller under the Transaction Documents;
|
(f)
|
those assets set forth on Schedule 2.2(f).
|
(b)
|
all Seller Expenses;
|
(d)
|
all Liabilities arising in connection with, or relating to, Excluded Taxes;
|
(g)
|
all Liabilities arising in connection with, or relating to, the Excluded Assets.
|
2.8
|
Payment of Estimated Closing Purchase Price. At the Closing, Buyer will pay in cash:
|
2.9
|
Determination of the Final Closing Purchase Price.
|
2.11
|
Closing Deliveries.
|
(ii)
|
the Assignment and Assumption Agreement, duly executed by Seller;
|
(viii)
|
the IP Assignment and Assumption Agreement, duly executed by Seller;
|
(ix)
|
the Escrow Agreement, duly executed by Seller;
|
(x)
|
the Leases, duly executed by the landlords party thereto;
|
(b)
|
At the Closing, Buyer will deliver or cause to be delivered the following:
|
(ii)
|
the Assignment and Assumption Agreement, duly executed by Buyer;
|
(iii)
|
the Leases, duly executed by Buyer;
|
(iv)
|
the Escrow Agreement, duly executed by Buyer;
|
(v)
|
the Noncompetition Agreements, duly executed by Buyer;
|
2.12
|
Earnout Payments.
|
(iii)
|
For each such Earnout Period, an additional amount (not to exceed
|
Earnout Period
|
Minimum Amount
|
Year One Earnout Period
|
$[*]
|
Year Two Earnout Period
|
$[*]
|
Year Three Earnout
Period
|
$[*]
|
Earnout Period
|
Minimum Installation
Services Revenue
|
Maximum Installation
Services Revenue
|
Year One Earnout Period
|
$[*]
|
$[*]
|
Year Two Earnout Period
|
$[*]
|
$[*]
|
Year Three Earnout Period
|
$[*]
|
$[*]
|
3.4
|
No Subsidiaries. Seller has no Subsidiaries other than those set forth on Schedule 3.4.
|
3.7
|
Financial Statements; Undisclosed Liabilities.
|
3.11
|
Compliance with Laws; Governmental Authorizations; Licenses.
|
3.13
|
Real Property.
|
(b)
|
Leased Real Property.
|
3.14
|
Taxes.
|
3.15
|
Environmental Matters.
|
3.16
|
Employee Matters.
|
3.17
|
Employee Benefit Plans.
|
(iii)
|
“cafeteria plan” (“125 Plan”) governed by Code Section 125; or
|
3.18
|
Intellectual Property Rights.
|
3.19
|
Material Contracts.
|
(xiii)
|
any commitment to do any of the foregoing described in clauses
|
3.21
|
Title to Assets.
|
3.24
|
Customers and Suppliers.
|
5.3
|
Commercially Reasonable Efforts; Notification of Certain Events.
|
5.5
|
Employee Matters.
|
5.7
|
Tax Matters.
|
5.9
|
Further Assurances.
|
5.10
|
Insurance.
|
7.2
|
Effect of Termination. If this Agreement is terminated pursuant to Section 7.1 hereof,
|
8.2
|
Indemnification.
|
(iii)
|
any Excluded Asset or Retained Liability;
|
(iv)
|
any items set forth on Schedule 8.2(a)(iv); and
|
8.3
|
Limitations on Liability; Calculation of Losses.
|
8.4
|
Claims Procedures.
|
(c)
|
Third Party Claims.
|
9.6
|
Assignment; Successors and Assigns; No Third Party Rights.
|
|
SELLER:
|
||
|
|
|
|
|
COLORADO LINING INTERNATIONAL, INC.
|
||
|
|
|
|
|
By:
|
/s/ John B. Heap
|
|
|
|
Name: John B. Heap
|
|
|
|
Title: President
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Patrick Elliot
|
|
|
|
Name: Patrick Elliot, Individually
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ John B. Heap
|
|
|
|
Name: John B. Heap, Individually
|
|
BUYER:
|
||
|
|
|
|
|
RAVEN INDUSTRIES, INC.
|
||
|
|
|
|
|
By:
|
/s/ Steven E. Brazones
|
|
|
|
Name: Steven E. Brazones
|
|
|
|
Title: Chief Financial Officer
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Raven Industries, Inc. (the Registrant);
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of, and for, the periods presented in this report;
|
4.
|
The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and
|
5.
|
The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of Registrant's board of directors (or others performing the equivalent function):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal controls over financial reporting.
|
Dated: November 21, 2017
|
/s/ Daniel A. Rykhus
|
|
Daniel A. Rykhus
|
|
President and Chief Executive Officer
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Raven Industries, Inc. (the Registrant);
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of, and for, the periods presented in this report;
|
4.
|
The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and
|
5.
|
The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of Registrant's board of directors (or others performing the equivalent function):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal controls over financial reporting.
|
Dated: November 21, 2017
|
/s/ Steven E. Brazones
|
|
Steven E. Brazones
|
|
Vice President and Chief Financial Officer
|
•
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
•
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Raven Industries, Inc.
|
Dated: November 21, 2017
|
/s/ Daniel A. Rykhus
|
|
Daniel A. Rykhus
|
|
President and Chief Executive Officer
|
•
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
•
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Raven Industries, Inc.
|
Dated: November 21, 2017
|
/s/ Steven E. Brazones
|
|
Steven E. Brazones
|
|
Vice President and Chief Financial Officer
|
|
|